Overview
Location
United States, Florida, Hollywood
Mentions in press and media 9
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 12, 2024 | CorFlow Therapeutics Secures €44 Million to Revolutionize Heart Attack Treatment | CorFlow Therapeutics is on a mission. The Swiss company has just raised €44 million in a Series B funding round, co-led by Broadview Ventures and Panakes Partners. This influx of capital is not just a financial boost; it’s a lifeline for pa... |
| Sep 12, 2024 | CorFlow Therapeutics raises €44 million in Series B round | Headquarted in Baar (Zug), CorFlow’s Controlled Flow Infusion (CoFI) system is being developed to provide timely, accurate and consistent detection of Microvascular Obstruction (MVO) while patients are still in the catheter laboratory (cat... |
| Sep 12, 2024 | CorFlow Therapeutics raises €44 million in Series B round | Co-led by Broadview Ventures and Panakes Partners, CoFlow’s series B round received strong continued support from 415 Capital, its initial VC investor and largest shareholder. Merieux Equity Partners, Laerdal Million Lives Fund, Wellington... |
| Dec 29, 2023 | LeaseTeq raises CHF8 million to digitize leasing | |
| Nov 14, 2023 | Hive-Zox closes CHF 3 million pre-series A round | |
| Jul 4, 2023 | AI-generated B2B video production tool Immersive Fox raises €3.3 million to further its capabilities | London-based Immersive Fox is putting AI into your B2B video production. The start-up specialises in AI-generated video to help users generate sales and customer communication or to deliver in-house videos, making it quicker, easier and mor... |
| Apr 14, 2020 | SwissDeCode selected by European Innovation Council for Covid-19 pitching event | SwissDeCode developed DNAFoil technology, a portable, self-administered, on-site DNA detection kit, which combines both food safety and compliance with regulatory bodies in a single tool. |
| Apr 14, 2020 | SwissDeCode selected by European Innovation Council for Covid-19 pitching event |
Reviews 0
FAQ about Monte Carlo Capital
What has the press written about Monte Carlo Capital?
Parsers VC has collected 9 articles mentioning Monte Carlo Capital, among them “CorFlow Therapeutics Secures €44 Million to Revolutionize Heart Attack Treatment” (Sep 12, 2024) and “CorFlow Therapeutics raises €44 million in Series B round” (Sep 12, 2024).
Is Monte Carlo Capital still active?
Yes, Monte Carlo Capital is active; its latest activity on Parsers VC dates from Mar 17, 2025.